| 2020 | Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis | BREAST CARE |
| 2019 | Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV
| ENDOCRINE-RELATED CANCER |
| 2019 | Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer
| JOURNAL OF BREAST CANCER |
| 2021 | Metastasis Risk Assessment Using BAG2 Expression by Cancer-Associated Fibroblast and Tumor Cells in Patients with Breast Cancer
| CANCERS |
| 2023 | Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1-2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy
| FRONTIERS IN ONCOLOGY |
| 2021 | PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
| SCIENTIFIC REPORTS |
| 2022 | Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR
| NPJ BREAST CANCER |
| 2023 | Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
| SCIENTIFIC REPORTS |
| 2022 | Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
| JOURNAL OF BREAST CANCER |
| 2020 | Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy
| SCIENTIFIC REPORTS |
| 2023 | Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer
| FRONTIERS IN ONCOLOGY |
| 2020 | Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer
| CANCERS |
| 2021 | Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
| FRONTIERS IN ONCOLOGY |
| 2021 | Relationship of the standard uptake value of 18 F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
| SCIENTIFIC REPORTS |
| 2020 | Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence After Breast Conserving Surgery With Sentinel Lymph Node Biopsy: Pooled Analysis Using Data From a Systematic Review and Two Institutions
| FRONTIERS IN ONCOLOGY |
| 2022 | Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis
| DIAGNOSTICS |
| 2023 | Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy | RADIOLOGY |
| 2022 | RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis | BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy | CLINICAL BREAST CANCER |
| 2022 | SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer
| CANCERS |
| 2021 | The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients
| PLOS ONE |
| 2021 | The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
| CANCERS |
| 2024 | Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer
| CANCERS |
| 2020 | Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
| SCIENTIFIC REPORTS |
| 2023 | YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
| CANCERS |
| 2016 | 공여자 우측 간 절제술 중 담도 내 탐침이기를 이용한 담도 절제의 유용성
| Journal of the Korean Society for Transplantation |
